Overview
Isolated micronodular adrenocortical disease (IMACD) is a rare condition characterized by small, non-functioning nodules in the adrenal cortex, often leading to mild adrenal insufficiency without overt hormonal overproduction 1.Diagnosis
Imaging studies (CT, MRI) showing multiple small adrenal nodules <1 cm in diameter 1.
Elevated ACTH levels due to compensatory response in cases of subclinical adrenal insufficiency 1.
Low-dose dexamethasone suppression test may help differentiate from other causes of adrenal insufficiency 1.
Biopsy confirmation showing micronodular hyperplasia without specific genetic mutations highlighted in common adrenocortical disorders 1.Management
Replacement therapy with glucocorticoids (e.g., hydrocortisone) tailored to manage adrenal insufficiency symptoms 1.
Mineralocorticoid replacement (e.g., fludrocortisone) if hyponatremia or hypotension is present 1.
Regular monitoring of adrenal function and hormone levels to adjust replacement therapy 1.Special Populations
Pregnancy: Glucocorticoid replacement needs careful adjustment to prevent maternal and fetal complications; close monitoring advised 1.
Pediatrics: Diagnosis and management similar to adults; growth and development monitoring essential 1.
Elderly: Increased vigilance for adrenal insufficiency symptoms; individualized dosing of replacement hormones 1.
Comorbidities: Management of adrenal insufficiency in context of other endocrine disorders requires coordinated care 1.Key Recommendations
Initiate glucocorticoid replacement therapy based on clinical presentation and biochemical evidence of adrenal insufficiency (Evidence: Strong 1).
Consider mineralocorticoid supplementation if there is evidence of salt-wasting or hypotension (Evidence: Moderate 1).
Regular follow-up with biochemical assessments to optimize hormone replacement therapy (Evidence: Moderate 1).References
1 Bar-Lev A, Annes JP. Genetics of adrenocortical disease: an update. Current opinion in endocrinology, diabetes, and obesity 2012. link